AlphaFold predicted structure
KDM2B · Q8NHM5

Mean pLDDT
67.8/ 100
Low
1,336 residues
Confidence breakdown
- Very high(≥ 90)38%
- Confident(70–90)19%
- Low(50–70)4%
- Very low(< 50)39%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
lysine demethylase 2B
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedhypertensive disorder
hereditary disease
essential hypertension
type 2 diabetes mellitus
diabetes mellitus
neurodegenerative disease
diabetic eye disease
diabetic retinopathy
Increased blood pressure
Global developmental delay
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Lysine-specific demethylase 2B
Histone demethylase that demethylates 'Lys-4' and 'Lys-36' of histone H3, thereby playing a central role in histone code (PubMed:16362057, PubMed:17994099, PubMed:26237645). Preferentially demethylates trimethylated H3 'Lys-4' and dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36' (PubMed:16362057, PubMed:17994099, PubMed:26237645). Preferentially binds the transcribed region of ribosomal RNA and represses the transcription of ribosomal RNA genes which inhibits cell growth and proliferation (PubMed:16362057, PubMed:17994099). May also serve as a substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex (Probable)
KDM2B · Q8NHM5

Mean pLDDT
67.8/ 100
Low
1,336 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0